Table 1 Description of the training and test series considered with number of samples/outliers
From: Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling
TRAINING SERIES | |||||
|---|---|---|---|---|---|
Series | Platform | Technology | Quality samples | Excluded outliers | Samples origin |
GSE52712 | Affymetrix | Microarray | 19 | 1 | Manchester (UK) |
GSE40987 | Affymetrix | Microarray | 10 | 0 | Boston (USA) |
GSE52262 | Affymetrix | Microarray | 16 | 0 | Houston (USA) |
GSE12790 | Affymetrix | Microarray | 20 | 1 | San Francisco (USA) |
GSE46834 | Illumina | Microarray | 8 | 0 | New York (USA) |
GSE68651 | Illumina | Microarray | 35 | 1 | Southampton (UK) |
GSE74251 | Illumina | RNA-Seq | 12 | 0 | Philadelphia (USA) |
GSE74377 | Illumina | RNA-Seq | 12 | 0 | Iowa (USA) |
TOTAL | Integrated | 132 | 3 | ||
TEST SERIES | |||||
Series | Platform | Technology | Quality samples | Excluded outliers | Samples origin |
GSE78011 | Illumina | RNA-Seq | 3 | 0 | Louisville (USA) |
GSE81593 | Illumina | RNA-Seq | 3 | 0 | New York (USA) |
GSE75292 | Illumina | Microarray | 6 | 1 | Goyang (South Korea) |
GSE29327 | Affymetrix | Microarray | 6 | 0 | South San Francisco (USA) |
GSE30931 | Illumina | Microarray | 12 | 0 | Goettingen (Germany) |
GSE48398 | Illumina | Microarray | 36 | 0 | Texas (USA) |
GSE35928 | Affymetrix | Microarray | 6 | 0 | Piscataway (USA) |
GSE57339 | Illumina | Microarray | 12 | 0 | New Haven (USA) |
GSE45715 | Illumina | Microarray | 42 | 0 | Miami (USA) |
TOTAL | Integrated | 126 | 1 | ||